mci 9038 has been researched along with Pneumonia, Viral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arachchillage, DJ; Hall, D; Laffan, M; Passariello, M; Patel, BV; Remmington, C; Rosenberg, A; Xu, T | 1 |
| Akiyama, T; Gohma, I; Kohata, H; Kohno, M; Kumasawa, J; Nagata, T; Nishida, K; Ogawa, Y | 1 |
| Daniels, LM; Sagardia, LM | 1 |
| Gandotra, P; Garra, G; Gruberg, L; Selim, S; Supariwala, A | 1 |
| Arnold, F; Biever, PM; Kalbhenn, J; Neumann-Haefelin, E; Rieg, S; Tanriver, Y; Walz, G; Westermann, L | 1 |
5 other study(ies) available for mci 9038 and Pneumonia, Viral
| Article | Year |
|---|---|
Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19.
Topics: Acute Disease; Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Cohort Studies; Coronavirus Infections; COVID-19; Female; Humans; Incidence; Male; Middle Aged; Pandemics; Pipecolic Acids; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thrombophilia | 2020 |
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Heparin; Host-Pathogen Interactions; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2020 |
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
Topics: Adult; Anticoagulants; Arginine; Coronavirus Infections; COVID-19; Fibrinolytic Agents; Heart Arrest; Heparin, Low-Molecular-Weight; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; Sulfonamides; Thrombolytic Therapy; Treatment Failure; Treatment Outcome | 2020 |
Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient.
Topics: Anticoagulants; Antithrombins; Aorta, Thoracic; Arginine; Biomarkers; COVID-19; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombosis | 2021 |
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Arginine; Betacoronavirus; Blood Coagulation; Citric Acid; Comorbidity; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Equipment Failure; Female; Germany; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pandemics; Pipecolic Acids; Pneumonia, Viral; Renal Replacement Therapy; Retrospective Studies; SARS-CoV-2; Sulfonamides; Tertiary Care Centers | 2020 |